Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
Charles Hsu will be a keynote speaker at the annual meeting of the Sino-American Pharmaceutical Association (West) in San Francisco
News | 04. 15. 2006
